Anchor Therapeutics Obtains $10,000,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f2f806cd-6102-4495-b69d-96766eca0b9b&Preview=1 -
Date
8/20/2010 -
Company Name
Anchor Therapeutics -
Mailing Address
67 Rogers St. Cambridge, MA 02142 -
Company Description
Anchor Therapeutics is developing first-in-class pepducin drug candidates, novel molecules that can selectively target G protein coupled receptors (GPCRs) to allosterically modulate GPCR signaling. -
Website
http://www.anchortx.com -
Transaction Type
Venture Equity -
Transaction Amount
$10,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
TVM Capital -
Venture Investor
HealthCare Ventures -
Venture Investor
Novartis BioVenture Fund
